New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

A Cleveland Clinic expert explains the signs that indicate a dementia patient is nearing the end of their life.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...

The authors define the “5 Love Languages,” (5LL), as: ...

A UCLA Health research team has identified changes in brain rhythms that indicate seizure activity in Alzheimer's patients.

The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

2025 — Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded ...

The study underscores the transformative potential of AI in Alzheimer’s diagnostics. ChatGPT’s ability to analyze EHRs, MRI scans, and cognitive assessments could aid early detection, allowing for ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...